Used as a key intermediate in the synthesis of antifungal agents, particularly in the production of triazole-based pharmaceuticals. Its structure supports the development of drugs that inhibit fungal cytochrome P450 enzymes, crucial for ergosterol biosynthesis. Commonly employed in the manufacture of systemic antifungals for treating infections such as candidiasis and aspergillosis. Also utilized in research for developing new antimicrobial compounds with improved bioavailability and resistance profiles.